In this study, we report a ligand-guided homology modeling approach allowing the analysis of relevant binding site residue conformations and the identification of two novel histamine H3 receptor ligands with binding affinity in the nanomolar range. The newly developed method is based on exploiting an essential charge interaction characteristic for aminergic G-protein coupled receptors for ranking 3D receptor models appropriate for the discovery of novel compounds through virtual screening.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592549 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0218820 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
Specificities of Protein Homology Modeling for Allosteric Drug Design.
Methods Mol Biol
March 2023
Faculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw, Warsaw, Poland.
The allosteric binding sites are usually located in the flexible areas of proteins, which are hardly visible in the crystal structures. However, there are notable exceptions like allosteric sites in receptors in class B and C of GPCRs, which are located within a well-defined bundle of transmembrane helices. Class B and C evolved from class A and even after swapping of orthosteric and allosteric sites the central binding site persisted and it can be used for easy design of allosteric drugs.
View Article and Find Full Text PDFLigand-guided homology modeling drives identification of novel histamine H3 receptor ligands.
PLoS One
February 2020
Molecular Design Lab, Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany.
In this study, we report a ligand-guided homology modeling approach allowing the analysis of relevant binding site residue conformations and the identification of two novel histamine H3 receptor ligands with binding affinity in the nanomolar range. The newly developed method is based on exploiting an essential charge interaction characteristic for aminergic G-protein coupled receptors for ranking 3D receptor models appropriate for the discovery of novel compounds through virtual screening.
View Article and Find Full Text PDFLigand-guided homology modelling of the GABAB2 subunit of the GABAB receptor.
PLoS One
August 2017
Department of Medical Biology, Faculty of Health Sciences, UiT - the Arctic University of Norway, Tromsø, Norway.
γ-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the central nervous system, and disturbances in the GABAergic system have been implicated in numerous neurological and neuropsychiatric diseases. The GABAB receptor is a heterodimeric class C G protein-coupled receptor (GPCR) consisting of GABAB1a/b and GABAB2 subunits. Two GABAB receptor ligand binding sites have been described, namely the orthosteric GABA binding site located in the extracellular GABAB1 Venus fly trap domain and the allosteric binding site found in the GABAB2 transmembrane domain.
View Article and Find Full Text PDFFrom Homology Models to a Set of Predictive Binding Pockets-a 5-HT Receptor Case Study.
J Chem Inf Model
February 2017
Institute of Pharmacology, Polish Academy of Sciences , 12 Smetna Street, 31-343 Kraków, Poland.
Despite its remarkable importance in the arena of drug design, serotonin 1A receptor (5-HT) has been elusive to the X-ray crystallography community. This lack of direct structural information not only hampers our knowledge regarding the binding modes of many popular ligands (including the endogenous neurotransmitter-serotonin), but also limits the search for more potent compounds. In this paper we shed new light on the 3D pharmacological properties of the 5-HT receptor by using a ligand-guided approach (ALiBERO) grounded in the Internal Coordinate Mechanics (ICM) docking platform.
View Article and Find Full Text PDFStrategies for improved modeling of GPCR-drug complexes: blind predictions of serotonin receptors bound to ergotamine.
J Chem Inf Model
July 2014
Science for Life Laboratory, Stockholm University, Box 1031, SE-171 21 Solna, Sweden.
The recent increase in the number of atomic-resolution structures of G protein-coupled receptors (GPCRs) has contributed to a deeper understanding of ligand binding to several important drug targets. However, reliable modeling of GPCR-ligand complexes for the vast majority of receptors with unknown structure remains to be one of the most challenging goals for computer-aided drug design. The GPCR Dock 2013 assessment, in which researchers were challenged to predict the crystallographic structures of serotonin 5-HT(1B) and 5-HT(2B) receptors bound to ergotamine, provided an excellent opportunity to benchmark the current state of this field.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!